{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:42:55Z","timestamp":1786164175014,"version":"build-2736575974"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7459-26","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T22:10:07Z","timestamp":1786140607000},"source":"Crossref","is-referenced-by-count":0,"title":["Insulinoma in Type 2 Diabetes Mellitus Becoming Clinically Evident in the Setting of Acute Kidney Injury: A Case with a Postoperative Deterioration of the Glucose Metabolism and a Quantitative Islet Cell Analysis"],"prefix":"10.2169","author":[{"given":"Hiroaki","family":"Akaoka","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hachioji Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hachioji Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hachioji Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719, 1991.","DOI":"10.1016\/S0025-6196(12)62083-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kurakawa KI, Okada A, Manaka K, et al. Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan. J Clin Endocrinol Metab 106: 3477-3486, 2021.","DOI":"10.1210\/clinem\/dgab559"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 94: 1069-1073, 2009.","DOI":"10.1210\/jc.2008-2031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chatterjee S, Bhattacharjee R, Ghosh R, Chakraborty PP, Sinha A, Maiti A. Insulinoma in patients with diabetes- A systematic review of previously reported cases. Indian J Endocrinol Metab 28: 554-561, 2024.","DOI":"10.4103\/ijem.ijem_154_24"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88: 2300-2308, 2003.","DOI":"10.1210\/jc.2002-020735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10: 32-42, 2008.","DOI":"10.1111\/j.1463-1326.2008.00969.x"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003.","DOI":"10.2337\/diabetes.52.1.102"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45: 85-96, 2002.","DOI":"10.1007\/s125-002-8248-z"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Mizukami H, Takahashi K, Inaba W, et al. Involvement of oxidative stress\u2013induced DNA damage, endoplasmic reticulum stress, and autophagy deficits in the decline of \u03b2-cell mass in Japanese Type 2 diabetic patients. Diabetes Care 37: 1966-1974, 2014.","DOI":"10.2337\/dc13-2018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bani Sacchi T, Bani D, Biliotti G. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations. Int J Pancreatol 5: 11-28, 1989.","DOI":"10.1007\/BF02925694"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Liu Z, Kim W, Chen Z, et al. Insulin and glucagon regulate pancreatic \u03b1-cell proliferation. PLOS One 6: e16096, 2011.","DOI":"10.1371\/journal.pone.0016096"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim BJ, Park HK, Shin JS, Kim KW. Increased alpha cells mass in surrounding pancreatic islet in insulinoma patients [Abstract]. J Endocr Soc 8: A426, 2024.","DOI":"10.1210\/jendso\/bvae163.814"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Sakaki K, Murakami T, Yoshida H, Otani D, Miyake KK, Shimizu Y, et al. Quantitative \u03b2-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes. Diabetes 75: 787-798, 2026.","DOI":"10.2337\/db25-1127"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7459-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:06:26Z","timestamp":1786161986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7459-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":13,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7459-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7459-26"}}